AstraZeneca PLC
NASDAQ:AZN

Watchlist Manager
AstraZeneca PLC Logo
AstraZeneca PLC
NASDAQ:AZN
Watchlist
Price: 78.02 USD -0.37% Market Closed
Market Cap: 241.9B USD
Have any thoughts about
AstraZeneca PLC?
Write Note

AstraZeneca PLC
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

AstraZeneca PLC
Accounts Payable Peer Comparison

Comparables:
GSK
INDV
HIK
DPH
A
APH

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
AstraZeneca PLC
LSE:AZN
Accounts Payable
$20.5B
CAGR 3-Years
5%
CAGR 5-Years
10%
CAGR 10-Years
7%
GlaxoSmithKline PLC
LSE:GSK
Accounts Payable
ÂŁ14.2B
CAGR 3-Years
0%
CAGR 5-Years
1%
CAGR 10-Years
7%
Indivior PLC
LSE:INDV
Accounts Payable
$46m
CAGR 3-Years
19%
CAGR 5-Years
13%
CAGR 10-Years
-1%
Hikma Pharmaceuticals PLC
LSE:HIK
Accounts Payable
$541m
CAGR 3-Years
34%
CAGR 5-Years
17%
CAGR 10-Years
16%
Dechra Pharmaceuticals PLC
LSE:DPH
Accounts Payable
ÂŁ144.5m
CAGR 3-Years
14%
CAGR 5-Years
14%
CAGR 10-Years
18%
A
Alliance Pharma PLC
LSE:APH
Accounts Payable
ÂŁ13.6m
CAGR 3-Years
10%
CAGR 5-Years
13%
CAGR 10-Years
18%

See Also

What is AstraZeneca PLC's Accounts Payable?
Accounts Payable
20.5B USD

Based on the financial report for Jun 30, 2024, AstraZeneca PLC's Accounts Payable amounts to 20.5B USD.

What is AstraZeneca PLC's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
7%

Over the last year, the Accounts Payable growth was 4%. The average annual Accounts Payable growth rates for AstraZeneca PLC have been 5% over the past three years , 10% over the past five years , and 7% over the past ten years .

Back to Top